J and J in talks with government to resolve Risperdal marketing investigation

According to the Dow Jones Newswires (11/10, Loftus) reported that Johnson & Johnson disclosed Wednesday that it is in talks with the government to settle an investigation into whether the company improperly marketed the antipsychotic Risperdal.